Cbdmd, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

AMEX
cbdMD is asking shareholders to vote on proposals including a reverse stock split and the conversion of Series A Preferred Stock to common stock at the upcoming annual meeting to address NYSE American listing requirements and improve the company's financial position.
AMEX
cbdMD, Inc. has filed a definitive proxy statement related to its upcoming shareholder meeting.
AMEX
cbdMD, Inc. has filed an investor presentation with the SEC in preparation for its Annual Meeting of Shareholders on March 29, 2024.